Loading...
XSTONNH
Market cap8mUSD
Dec 23, Last price  
15.00SEK
1D
0.00%
1Q
-7.41%
Jan 2017
-45.45%
IPO
-70.30%
Name

New Nordic Healthbrands AB

Chart & Performance

D1W1MN
XSTO:NNH chart
P/E
—
P/S
0.17
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
6.28%
Revenues
534m
+9.51%
201,200,000225,594,000195,302,000199,479,000203,787,000227,983,000271,949,000298,485,000305,842,000344,739,000393,708,000452,613,000450,064,000514,845,000487,501,000533,849,000
Net income
-6m
L+119.41%
-14,391,000934,000-5,729,000311,000-4,086,0005,781,00012,375,00011,330,0009,574,00020,297,00026,523,00028,074,00017,765,00021,303,000-2,823,000-6,194,000
CFO
28m
P
4,859,00010,374,0002,024,000875,0004,167,000483,0003,204,000-2,560,0001,624,00026,420,00017,852,000-667,00019,680,000-7,870,000-15,451,00028,027,000
Dividend
Apr 29, 20221.25 SEK/sh

Profile

New Nordic Healthbrands AB (publ) develops and markets dietary supplements, natural medicines, and cosmetic products in Sweden. The company provides vitality products for immune system. The company provides balm, repair mask, shampoo, shine serum, chewing gum, face and eye cream, and dietary supplements. It offers its products under Hair Volume, Skin Care, Beauty In & Out, and New Nordic brand names. The company sells its products through pharmacies, department stores, health stores, travel retailers, and beauty shops, as well as through online stores in 41 countries in North America, Canada, Europe, the United States, and internationally. New Nordic Healthbrands AB (publ) was founded in 1990 and is headquartered in Malmö, Sweden.
URL
https://newnordic.se/
IPO date
Jan 23, 2007
Employees
74
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
533,849
9.51%
487,501
-5.31%
514,845
14.39%
Cost of revenue
186,292
169,576
429,721
Unusual Expense (Income)
NOPBT
347,557
317,925
85,124
NOPBT Margin
65.10%
65.22%
16.53%
Operating Taxes
280
(2,343)
6,653
Tax Rate
0.08%
7.82%
NOPAT
347,277
320,268
78,471
Net income
(6,194)
119.41%
(2,823)
-113.25%
21,303
19.92%
Dividends
(7,744)
(9,293)
Dividend yield
4.31%
1.70%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
30,692
48,347
24,426
Long-term debt
1,649
Deferred revenue
Other long-term liabilities
2,183
1,237
Net debt
16,879
31,746
11,910
Cash flow
Cash from operating activities
28,027
(15,451)
(7,870)
CAPEX
(2,144)
(2,954)
(2,710)
Cash from investing activities
(3,396)
(2,619)
(2,971)
Cash from financing activities
(21,171)
16,589
12,071
FCF
378,964
307,917
45,766
Balance
Cash
13,813
10,703
11,884
Long term investments
7,547
632
Excess cash
Stockholders' equity
106,030
218,949
120,834
Invested Capital
134,854
160,912
142,415
ROIC
234.83%
211.17%
63.07%
ROCE
256.46%
197.58%
58.88%
EV
Common stock shares outstanding
6,195
6,195
6,195
Price
16.65
-42.59%
29.00
-67.19%
88.40
55.63%
Market cap
103,147
-42.59%
179,655
-67.20%
547,656
55.63%
EV
120,026
211,401
559,566
EBITDA
349,451
319,569
86,059
EV/EBITDA
0.34
0.66
6.50
Interest
2,826
1,525
592
Interest/NOPBT
0.81%
0.48%
0.70%